93 related articles for article (PubMed ID: 7899792)
21. In vitro study of the anti-leishmanial activity of biodegradable nanoparticles.
Venier-Julienne MC; Vouldoukis I; Monjour L; Benoit JP
J Drug Target; 1995; 3(1):23-9. PubMed ID: 7655817
[TBL] [Abstract][Full Text] [Related]
22. Toxicological study of the primaquine phosphate loaded chitosan nanoparticles in mice.
Rajera R; Nagpal K; Singh SK; Mishra DN
Int J Biol Macromol; 2013 Nov; 62():18-24. PubMed ID: 23973494
[TBL] [Abstract][Full Text] [Related]
23. Leishmania donovani: pilot study for evaluation of therapeutic effects of inosine analogs against amastigotes in vitro and in vivo.
Morishige K; Aji T; Ishii A; Yasuda T; Wataya Y
Exp Parasitol; 1995 Jun; 80(4):665-71. PubMed ID: 7758547
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic evaluation of free and liposome-loaded furazolidone in experimental visceral leishmaniasis.
Tempone AG; Mortara RA; de Andrade HF; Reimão JQ
Int J Antimicrob Agents; 2010 Aug; 36(2):159-63. PubMed ID: 20554161
[TBL] [Abstract][Full Text] [Related]
25. The sensitivity of Leishmania species to aminosidine.
Neal RA; Allen S; McCoy N; Olliaro P; Croft SL
J Antimicrob Chemother; 1995 May; 35(5):577-84. PubMed ID: 7592170
[TBL] [Abstract][Full Text] [Related]
26. Ultrastructural changes in parasites induced by nanoparticle-bound pentamidine in a Leishmania major/mouse model.
Fusai T; Boulard Y; Durand R; Paul M; Bories C; Rivollet D; Astier A; Houin R; Deniau M
Parasite; 1997 Jun; 4(2):133-9. PubMed ID: 9296058
[TBL] [Abstract][Full Text] [Related]
27. Spinigerin induces apoptotic like cell death in a caspase independent manner in Leishmania donovani.
Sardar AH; Das S; Agnihorti S; Kumar M; Ghosh AK; Abhishek K; Kumar A; Purkait B; Ansari MY; Das P
Exp Parasitol; 2013 Dec; 135(4):715-25. PubMed ID: 24184774
[TBL] [Abstract][Full Text] [Related]
28. A mixed Th1/Th2 response elicited by a liposomal formulation of Leishmania vaccine instructs Th1 responses and resistance to Leishmania donovani in susceptible BALB/c mice.
Mazumdar T; Anam K; Ali N
Vaccine; 2004 Mar; 22(9-10):1162-71. PubMed ID: 15003644
[TBL] [Abstract][Full Text] [Related]
29. Asiaticoside induces tumour-necrosis-factor-α-mediated nitric oxide production to cure experimental visceral leishmaniasis caused by antimony-susceptible and -resistant Leishmania donovani strains.
Bhaumik SK; Paul J; Naskar K; Karmakar S; De T
J Antimicrob Chemother; 2012 Apr; 67(4):910-20. PubMed ID: 22258930
[TBL] [Abstract][Full Text] [Related]
30. Protective therapy with novel chromone derivative against Leishmania donovani infection induces Th1 response in vivo.
Mallick S; Dutta A; Ghosh J; Maiti S; Mandal AK; Banerjee R; Bandyopadhyay C; Pal C
Chemotherapy; 2011; 57(5):388-93. PubMed ID: 22024637
[TBL] [Abstract][Full Text] [Related]
31. Antileishmanial activity of the ether phospholipid ilmofosine.
Croft SL; Neal RA; Thornton EA; Herrmann DB
Trans R Soc Trop Med Hyg; 1993; 87(2):217-9. PubMed ID: 8337733
[TBL] [Abstract][Full Text] [Related]
32. Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines.
Sarkar K; Das PK
J Immunol; 1997 Jun; 158(11):5357-65. PubMed ID: 9164956
[TBL] [Abstract][Full Text] [Related]
33. Potential of doxorubicin as an antileishmanial agent.
Sett R; Basu N; Ghosh AK; Das PK
J Parasitol; 1992 Apr; 78(2):350-4. PubMed ID: 1556650
[TBL] [Abstract][Full Text] [Related]
34. Lymphokine mediated microbicidal activity of peritoneal macrophages from Leishmania donovani infected and drug treated BALB/c mice.
Sodhi S; Ganguly NK; Malla N; Mahajan RC
Jpn J Exp Med; 1989 Jun; 59(3):103-8. PubMed ID: 2554031
[TBL] [Abstract][Full Text] [Related]
35. Protective effect of Croton caudatus Geisel leaf extract against experimental visceral leishmaniasis induces proinflammatory cytokines in vitro and in vivo.
Dey S; Mukherjee D; Chakraborty S; Mallick S; Dutta A; Ghosh J; Swapana N; Maiti S; Ghorai N; Singh CB; Pal C
Exp Parasitol; 2015; 151-152():84-95. PubMed ID: 25655407
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo prophylactic and curative activity of the triterpene saponin PX-6518 against cutaneous Leishmania species.
Inocêncio da Luz RA; Vermeersch M; Deschacht M; Hendrickx S; Van Assche T; Cos P; Maes L
J Antimicrob Chemother; 2011 Feb; 66(2):350-3. PubMed ID: 21131319
[TBL] [Abstract][Full Text] [Related]
37. Mannosylated thiolated paromomycin-loaded PLGA nanoparticles for the oral therapy of visceral leishmaniasis.
Afzal I; Sarwar HS; Sohail MF; Varikuti S; Jahan S; Akhtar S; Yasinzai M; Satoskar AR; Shahnaz G
Nanomedicine (Lond); 2019 Feb; 14(4):387-406. PubMed ID: 30688557
[TBL] [Abstract][Full Text] [Related]
38. Activity of pentamidine-loaded methacrylate nanoparticles against Leishmania infantum in a mouse model.
Durand R; Paul M; Rivollet D; Houin R; Astier A; Deniau M
Int J Parasitol; 1997 Nov; 27(11):1361-7. PubMed ID: 9421724
[TBL] [Abstract][Full Text] [Related]
39. Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi.
Reimão JQ; Colombo FA; Pereira-Chioccola VL; Tempone AG
Exp Parasitol; 2012 Mar; 130(3):195-9. PubMed ID: 22281156
[TBL] [Abstract][Full Text] [Related]
40. Leishmanicidal activity assessment of olive tree extracts.
Kyriazis JD; Aligiannis N; Polychronopoulos P; Skaltsounis AL; Dotsika E
Phytomedicine; 2013 Feb; 20(3-4):275-81. PubMed ID: 23273752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]